Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study to Investigate the Possible Efficacy and Safety of Montleukast in Parkinson Disease

NCT06113640 is registered in ClinicalTrials.gov with Mostafa Bahaa as lead sponsor.

NCT NCT06113640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06113640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study to Investigate the Possible Efficacy and Safety of Montleukast in Parkinson Disease
Lead sponsor
Mostafa Bahaa
Phase
Phase 2/3
Overall status
Completed
Start date
November 5, 2023
Completion date
August 20, 2026
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease